Pediatric Quality of Life Instruments in Oral Health Research: A Systematic Review
To identify the generic or disease-specific pediatric quality of life (QoL) instruments used in oral health research among children and adolescents and to provide an overview of these QoL instruments. (Source: Value in Health)
Source: Value in Health - September 8, 2018 Category: International Medicine & Public Health Authors: Ruvini M. Hettiarachchi, Sanjeewa Kularatna, Joshua Byrnes, Paul A. Scuffham Source Type: research

Assessing the Cost Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women
Several specialty societies have recently updated their breast cancer screening guidelines in late 2015/early 2016. (Source: Value in Health)
Source: Value in Health - September 7, 2018 Category: International Medicine & Public Health Authors: Ya-Chen Tina Shih, Wenli Dong, Ying Xu, Yu Shen Source Type: research

Evaluating the Impact of Using a Generic versus a Disease-Specific Quality-of-Life Instrument in Cost-Utility Analyses: A Case Study in Severe Asthma
To compare a generic versus disease-specific measure of health-related quality of life in terms of their psychometric properties and influence on cost-effectiveness analysis in severe asthma. (Source: Value in Health)
Source: Value in Health - September 4, 2018 Category: International Medicine & Public Health Authors: Necdet B. Gunsoy, Scott Doyle, Sarah M. Cockle, Robyn von Maltzahn, Yumi Asukai Source Type: research

Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force
Constrained optimization methods are already widely used in health care to solve problems that represent traditional applications of operations research methods, such as choosing the optimal location for new facilities or making the most efficient use of operating room capacity. (Source: Value in Health)
Source: Value in Health - September 1, 2018 Category: International Medicine & Public Health Authors: William Crown, Nasuh Buyukkaramikli, Mustafa Y. Sir, Praveen Thokala, Alec Morton, Deborah A. Marshall, Jonathan C. Tosh, Maarten J. Ijzerman, William V. Padula, Kalyan S. Pasupathy Tags: ISPOR Report Source Type: research

Editorial Board
(Source: Value in Health)
Source: Value in Health - September 1, 2018 Category: International Medicine & Public Health Source Type: research

Table of Contents
(Source: Value in Health)
Source: Value in Health - September 1, 2018 Category: International Medicine & Public Health Source Type: research

Copyright/Subscription
(Source: Value in Health)
Source: Value in Health - September 1, 2018 Category: International Medicine & Public Health Source Type: research

Perceptions of Response Burden Associated with Completion of Patient-Reported Outcome Assessments in Oncology
Patient response burden is often raised as a human subject concern in consideration of the length or complexity of patient-reported outcome (PRO) instruments used in oncology. (Source: Value in Health)
Source: Value in Health - August 30, 2018 Category: International Medicine & Public Health Authors: Thomas M. Atkinson, Carolyn E. Schwartz, Leah Goldstein, Iliana Garcia, Daniel F. Storfer, Yuelin Li, Jie Zhang, Bernard H. Bochner, Bruce D. Rapkin Source Type: research

Economic Evaluation of Stem Cell Therapies in Neurological Diseases: A Systematic Review
To examine economic evaluation studies of stem cell therapies (SCTs) in neurological disorders and to provide an overview of the quality of the economic evidence available on this topic. (Source: Value in Health)
Source: Value in Health - August 30, 2018 Category: International Medicine & Public Health Authors: Anjali Nagpal, Rachel Milte, Susan W. Kim, Susan Hillier, Monica A. Hamilton-Bruce, Julie Ratcliffe, Simon A. Koblar Source Type: research

Cost Effectiveness of a Comprehensive Approach for Hypertension Control in Low-Income Settings in Argentina: Trial-Based Analysis of the Hypertension Control Program in Argentina
A recent cluster randomized trial evaluating a multicomponent intervention showed significant reductions in blood pressure in low-income hypertensive subjects in Argentina. (Source: Value in Health)
Source: Value in Health - August 29, 2018 Category: International Medicine & Public Health Authors: Federico Augustovski, Mart ín Chaparro, Alfredo Palacios, Lizheng Shi, Andrea Beratarrechea, Vilma Irazola, Adolfo Rubinstein, Katherine Mills, Jiang He, Andrés Pichon Riviere Source Type: research

Equity Weights for Socioeconomic Position: Two Methods —Survey of Stated Preferences and Epidemiological Data
There is an implicit equity approach in cost-effectiveness analysis that values health gains of socioeconomic position groups equally. An alternative approach is to integrate equity by weighting quality-adjusted life-years according to the socioeconomic position group. (Source: Value in Health)
Source: Value in Health - August 28, 2018 Category: International Medicine & Public Health Authors: Anita Lal, Mohammadreza Mohebi, Rohan Sweeney, Marjory Moodie, Anna Peeters, Rob Carter Source Type: research

Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons (MAICs) via a Common Comparator
Adjusted indirect comparisons (anchored via a common comparator) are an integral part of health technology assessment. These methods are challenged when differences between studies exist, including inclusion/exclusion criteria, outcome definitions, patient characteristics, as well as ensuring the choice of a common comparator. (Source: Value in Health)
Source: Value in Health - August 23, 2018 Category: International Medicine & Public Health Authors: Helmut Petto, Zbigniew Kadziola, Alan Brnabic, Daniel Saure, Mark Belger Source Type: research

HIQA ’s Perspective on the Challenges Posed by Evaluations of Screening Programs: A Reply
Teljeur et al. [1] recently replied to a critique of the Health Information and Quality Authority ’s (HIQA’s) decision to publish average cost-effectiveness ratios (ACERs) as incremental cost-effectiveness ratios (ICERs) in a health technology assessment (HTA) [2]. The reply raises important questions about the attitude of Ireland’s HTA authority toward simulation analysis and merits furth er comment. (Source: Value in Health)
Source: Value in Health - August 23, 2018 Category: International Medicine & Public Health Authors: James F. O ’Mahony Tags: CORRESPONDENCE Source Type: research

Assessing the Value of Next-Generation Sequencing Technologies: An Introduction
Themed sections in Value in Health provide readers an opportunity to learn more about a specific contemporary issue in health care, research, or policy from several perspectives. This issue of Value in Health includes a themed section on assessing the value of precision or personalized medicine —the use of genomics to target health care interventions. We focus specifically on next-generation sequencing (NGS) technologies, which are the fastest growing type of precision medicine technology [1]. Genetic testing is evolving from the use of single-gene tests toward the use of more complex te sts that measure multiple gen...
Source: Value in Health - August 22, 2018 Category: International Medicine & Public Health Authors: Kathryn A. Phillips Tags: Editorial Source Type: research

Assessing Emotional Functioning with Increased Power: Relative Validity of a Customized EORTC Short Form in the International ACTION Trial
There is a need to improve the assessment of emotional functioning (EF). In the international Advance Care Planning: an Innovative Palliative Care Intervention to Improve Quality of Life in Cancer Patients - a Multi-Centre Cluster Randomized Clinical Trial (ACTION) trial involving patients with advanced cancer, EF was assessed by a customized 10-item short form (EF10). The EF10 is based on the European Organisation for Research and Treatment of Cancer (EORTC) EF item bank and has the potential for greater precision than the common EORTC Quality of Life Questionnaire Core 30 four-item scale (EF4). (Source: Value in Health)
Source: Value in Health - August 20, 2018 Category: International Medicine & Public Health Authors: Lea J. Jabbarian, Mogens Groenvold, Morten Aa. Petersen, Caroline Arnfeldt Christensen, Luc Deliens, Agnes van der Heide, Marijke C. Kars, Guido Miccinesi, Sheila Payne, Andrew Wilcock, Ida J. Korfage, on behalf of the ACTION consortium Source Type: research

The Retraction of a Trial Included in a Meta-Analysis of Interventions to Enhance Oral Medication Adherence
We are writing to draw the attention of the editors to the retraction of a trial by Zolfaghari et al. [1] that was included in the Zomahoun et al. [2] systematic review and meta-analysis published in Value in Health. The aim of the review was to establish the effectiveness of interventions to improve adherence in patients taking oral medication for diabetes. The authors included randomized and nonrandomized studies with usual care or active comparator interventions. Searches were performed in September 2013, and the article was published online on May 22, 2015. (Source: Value in Health)
Source: Value in Health - August 20, 2018 Category: International Medicine & Public Health Authors: Richard Gray, Amal Al-Ghareeb, Jenny Davis, Lisa McKenna, Stav Amichai Hillel Tags: Correspondence Source Type: research

Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions
Next-generation sequencing (NGS) technologies have seen variable adoption in the clinic. This is partly due to a lack of clinical and economic studies, with the latter increasingly challenged to examine patient preferences for health and nonhealth outcomes (e.g., false-positive rate). (Source: Value in Health)
Source: Value in Health - August 18, 2018 Category: International Medicine & Public Health Authors: Dean A. Regier, Deirdre Weymann, James Buchanan, Deborah A. Marshall, Sarah Wordsworth Source Type: research

Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions
Next-generation sequencing (NGS) is considered to be a prominent example of “big data” because of the quantity and complexity of data it produces and because it presents an opportunity to use powerful information sources that could reduce clinical and health economic uncertainty at a patient level. One obstacle to translating NGS into routine health care has been a lack of clinical trials evaluating NGS technologies, which could be used to populate cost-effectiveness analyses (CEAs). A key question is whether big data can be used to partially support CEAs of NGS. (Source: Value in Health)
Source: Value in Health - August 17, 2018 Category: International Medicine & Public Health Authors: Sarah Wordsworth, Brett Doble, Katherine Payne, James Buchanan, Deborah A. Marshall, Christopher McCabe, Dean A. Regier Source Type: research

Selecting Bolt-On Dimensions for the EQ-5D: Examining Their Contribution to Health-Related Quality of Life
Generic preference-based measures may miss dimensions important for the health-related quality of life (HRQOL) of patients. When this happens, a possible solution is to add bolt-ons. Finch et al. (Finch AP, Brazier JE, Mukuria C, Bjorner JB. An exploratory study on using principal component analysis and confirmatory factor analysis to identify bolt-on dimensions: the EQ-5D case study. Value Health 2017;10:1362 –75) have recently shown that bolt-ons can be systematically identified using factor analysis. (Source: Value in Health)
Source: Value in Health - August 16, 2018 Category: International Medicine & Public Health Authors: Aureliano Paolo Finch, John Edward Brazier, Clara Mukuria Source Type: research

Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project
To summarize lessons learned while analyzing the costs of integrating whole genome sequencing into the care of cardiology and primary care patients in the MedSeq Project by conducting the first randomized controlled trial of whole genome sequencing in general and specialty medicine. (Source: Value in Health)
Source: Value in Health - August 13, 2018 Category: International Medicine & Public Health Authors: Kurt D. Christensen, Kathryn A. Phillips, Robert C. Green, Dmitry Dukhovny Source Type: research

Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping
Preference-based measures of health, such as the three-level EuroQol five-dimensional questionnaire (EQ-5D-3L), are required to calculate quality-adjusted life-years for use in cost-effectiveness analysis, but are often not recorded in clinical studies. In these cases, mapping can be used to estimate preference-based measures. (Source: Value in Health)
Source: Value in Health - August 9, 2018 Category: International Medicine & Public Health Authors: Laura A. Gray, Allan J. Wailoo, Monica Hernandez Alava Source Type: research

Identifying Patients with Relapsing-Remitting Multiple Sclerosis Using Algorithms Applied to US Integrated Delivery Network Health Care Data
Relapsing-remitting multiple sclerosis (RRMS) has a major impact on affected patients; therefore, improved understanding of RRMS is important, particularly in the context of real-world evidence. (Source: Value in Health)
Source: Value in Health - August 9, 2018 Category: International Medicine & Public Health Authors: Hoa Van Le, Chi Thi Le Truong, Aaron W.C. Kamauu, John Holm én, Christopher Fillmore, Monica G. Kobayashi, Canter Martin, Meritxell Sabidó, Schiffon L. Wong Source Type: research

Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled “Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis”
We thank the editor for giving us the opportunity to reply to this letter to the editor. In this letter, the authors raise concerns about our article titled “Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis” and about the publication and review process of systematic reviews and meta-analyses. More specifically, the letter raises three m ain issues. The first two issues refer to the responsibilities of authors and editors/reviewers, whereas the third issue refers to the effect the retraction of one ...
Source: Value in Health - August 9, 2018 Category: International Medicine & Public Health Authors: Herv é Tchala Vignon Zomahoun, Marijn de Bruin, Laurence Guillaumie, Jocelyne Moisan, Jean-Pierre Grégoire, Norma Pérez, Lydi-Anne Vézina-Im, Line Guénette Tags: Letter to the Editor Source Type: research

Are We Ready to use Constrained Optimization in Health Outcomes Research?
Decision-analytic modeling is an accepted approach used by many health technology assessment agencies to assess the cost-effectiveness (i.e., value) of new and existing health care technologies [1,2]. These agencies (along with payers, physicians, and other stakeholders) recognize that decision analysis can be used to forecast health outcomes and to understand the value of medical technologies based on clinical trial data before they are used in clinical practice. In fact, decision modeling as an analysis tool has expanded and helps us to understand a variety of additional outcomes issues associated with health care, inclu...
Source: Value in Health - August 9, 2018 Category: International Medicine & Public Health Authors: Stephanie R. Earnshaw Tags: Editorial Source Type: research

Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective
Valuations of health states were affected by the wording of the two instruments (EQ-5D-3L and EQ-5D-Y) and by the perspective taken (child or adult). (Source: Value in Health)
Source: Value in Health - August 8, 2018 Category: International Medicine & Public Health Authors: Simone Kreimeier, Mark Oppe, Juan M. Ramos-Go ñi, Amanda Cole, Nancy Devlin, Michael Herdman, Brendan Mulhern, Koonal K. Shah, Elly Stolk, Oliver Rivero-Arias, Wolfgang Greiner Source Type: research

Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions
Clinical use of next-generation sequencing (NGS) tests has been increasing, but few studies have examined their economic value. Several studies have noted that there are methodological challenges to conducting economic evaluations of NGS tests. (Source: Value in Health)
Source: Value in Health - August 8, 2018 Category: International Medicine & Public Health Authors: Kathryn A. Phillips, Patricia A. Deverka, Deborah A. Marshall, Sarah Wordsworth, Dean A. Regier, Kurt D. Christensen, James Buchanan Source Type: research

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing
Next-generation sequencing promises major advancements in precision medicine but faces considerable challenges with insurance coverage. These challenges are especially important to address in oncology in which next-generation tumor sequencing (NGTS) holds a particular promise, guiding the use of life-saving or life-prolonging therapies. Payers ’ coverage decision making on NGTS is challenging because this revolutionary technology pushes the very boundaries of the underlying framework used in coverage decisions. (Source: Value in Health)
Source: Value in Health - August 3, 2018 Category: International Medicine & Public Health Authors: Julia R. Trosman, Christine B. Weldon, William J. Gradishar, Al B. Benson, Massimo Cristofanilli, Allison W. Kurian, James M. Ford, Alan Balch, John Watkins, Kathryn A. Phillips Source Type: research

Editorial Board
(Source: Value in Health)
Source: Value in Health - August 1, 2018 Category: International Medicine & Public Health Source Type: research

Table of Contents
(Source: Value in Health)
Source: Value in Health - August 1, 2018 Category: International Medicine & Public Health Source Type: research

Copyright/Subscription
(Source: Value in Health)
Source: Value in Health - August 1, 2018 Category: International Medicine & Public Health Source Type: research

The Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice
The current five-level EQ-5D (EQ-5D-5L) valuation protocol requires the valuation of 86 states. It has been demonstrated that the selection of empirically valued health states affects the extrapolated values in three-level EQ-5D (EQ-3D-3L). In this investigation, we aim to compare the performance of the current EQ-5D-5L valuation design with other designs. (Source: Value in Health)
Source: Value in Health - August 1, 2018 Category: International Medicine & Public Health Authors: Zhihao Yang, Nan Luo, Gouke Bonsel, Jan Busschbach, Elly Stolk Source Type: research

Market Consolidation and Mortality in Patients Initiating Hemodialysis
It is uncertain whether consolidation in health care markets affects the quality of care provided and health outcomes. (Source: Value in Health)
Source: Value in Health - July 27, 2018 Category: International Medicine & Public Health Authors: Kevin F. Erickson, Wolfgang C. Winkelmayer, Vivian Ho, Jay Bhattacharya, Glenn M. Chertow Source Type: research

Impact of Non-adherence and Flare Resolution on the Cost Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model
Dual urate-lowering therapy (ULT) with lesinurad in combination with either allopurinol or febuxostat is an option for patients with gout unsuccessfully treated on either monotherapy. Treatment failure is often a result of poor medication adherence. Imperfect adherence in clinical trials may lead to biased estimates of treatment effect and confound the results of cost-effectiveness analyses. (Source: Value in Health)
Source: Value in Health - July 26, 2018 Category: International Medicine & Public Health Authors: Daniel Hill-McManus, Scott Marshall, Elena Soto, Steven Lane, Dyfrig Hughes Source Type: research

Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
It is an unresolved issue as to whether cost-benefit analysis (CBA) or cost-effectiveness analysis (CEA) is the preferable analytical toolkit for use in health technology assessment (HTA). The distinction between the two and an expressed preference for CEA go back at least to 1980 in the USA and, most recently, a Harvard-based group has been reappraising the case for CBA. (Source: Value in Health)
Source: Value in Health - July 26, 2018 Category: International Medicine & Public Health Authors: Anthony J. Culyer, Kalipso Chalkidou Source Type: research

Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease
The Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) is the preferred measure of health outcome in clinical trials in motor neuron disease (MND). It, however, does not provide a preference-based health utility score required for estimating quality-adjusted life-years in economic evaluations for health technology assessments. (Source: Value in Health)
Source: Value in Health - July 25, 2018 Category: International Medicine & Public Health Authors: Alan Moore, Carolyn A. Young, Dyfrig A. Hughes Source Type: research

Performance of a Bayesian Approach for Imputing Missing Data on the SF-12 Health-Related Quality-of-Life Measure
Missing data in health-related quality-of-life outcomes are an ongoing problem. The 12-item short form health survey (SF-12) scores are no exception. Data imputation is complicated, because missingness may be partially predicted by the missing data themselves. (Source: Value in Health)
Source: Value in Health - July 24, 2018 Category: International Medicine & Public Health Authors: Alex S. Halme, Cara Tannenbaum Source Type: research

Cost-Utility Analysis of Apixaban versus Warfarin in Atrial Fibrillation Patients with Chronic Kidney Disease
Warfarin use for stroke prevention in atrial fibrillation (AF) patients with chronic kidney disease is debated. Apixaban was shown to be safer than warfarin, with superior reduction in the risk of stroke, systemic embolism, mortality, and major bleeding irrespective of kidney function. (Source: Value in Health)
Source: Value in Health - July 24, 2018 Category: International Medicine & Public Health Authors: Shoroq M. Altawalbeh, Osama Y. Alshogran, Kenneth J. Smith Source Type: research

A Systematic Review of Patient-Reported Satisfaction with Oral Medication Therapy in Patients with Type 2 Diabetes
The systematic review provides a detailed description and evaluation of all available in English with medication instruments used for type 2 diabetes oral medications. (Source: Value in Health)
Source: Value in Health - July 16, 2018 Category: International Medicine & Public Health Authors: Yu Wang, Matthew Perri Source Type: research

Calculating the Expected Value of Sample Information Using Efficient Nested Monte Carlo: A Tutorial
The expected value of sample information (EVSI) quantifies the economic benefit of reducing uncertainty in a health economic model by collecting additional information. This has the potential to improve the allocation of research budgets. Despite this, practical EVSI evaluations are limited partly due to the computational cost of estimating this value using the gold-standard nested simulation methods. Recently, however, Heath et al. developed an estimation procedure that reduces the number of simulations required for this gold-standard calculation. (Source: Value in Health)
Source: Value in Health - July 16, 2018 Category: International Medicine & Public Health Authors: Anna Heath, Gianluca Baio Source Type: research

COMMENTARY Realizing the “Great Potential” of MCDA in HTA
We read with interest the insightful article by Marsh et al. [1], “The Use of MCDA in HTA: Great Potential, but More Effort Needed.” In the article, the authors describe three challenges to the use of multicriterion decision analysis (MCDA): the use of additive models, a lack of connection between criteria scales and weights, and the use of MCDA in economic ev aluation. The authors offer several suggestions for improving current methods including more careful consideration of criteria to avoid overlap and maintain independence, greater precision in the development of “ranges of consequences” and &ld...
Source: Value in Health - July 16, 2018 Category: International Medicine & Public Health Authors: William Hall, Craig Mitton, Adrian Levy Source Type: research

Time Is Money: Investigating the Value of Leisure Time and Unpaid Work
This study investigated the monetary value of unpaid work and leisure time to enable the inclusion of patient time in economic evaluations. (Source: Value in Health)
Source: Value in Health - July 15, 2018 Category: International Medicine & Public Health Authors: Kaya Verbooy, Renske Hoefman, Job van Exel, Werner Brouwer Source Type: research

Does Inclusion of Interactions Result in Higher Precision of Estimated Health State Values?
Most preference-based instruments producing overall values for health states are devised on the simplifying assumption that the overall effect of distinct health-related quality of life domains (attributes) of the instrument equals the sum of the attributes. Nevertheless, health attributes are often inter-related and depend on each other. (Source: Value in Health)
Source: Value in Health - July 15, 2018 Category: International Medicine & Public Health Authors: Anna Nicolet, Catharina G.M. Groothuis-Oudshoorn, Paul F.M. Krabbe Source Type: research

A Rights-Based Approach for Service Providers to Measure the Quality of Life of Children with a Disability
This paper identifies the best instruments for service providers to measure the quality of life (QoL) of children with a disability, with a focus on their alignment with the Convention on the Rights of Persons with a Disability (CRPD). (Source: Value in Health)
Source: Value in Health - July 10, 2018 Category: International Medicine & Public Health Authors: Elise Davis, Dana Young, Kim-Michelle Gilson, Elena Swift, Jeffrey Chan, Lisa Gibbs, Utsana Tonmukayakul, Dinah Reddihough, Katrina Williams Source Type: research

Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
To explore how the use of EQ-5D-5L value set and crosswalk from EQ-5D-5L to EQ-5D-3L (and use of 3L value set) would affect cost-effectiveness analysis results for England and six other countries (Canada, the Netherlands, China, Japan, South Korea, and Singapore). (Source: Value in Health)
Source: Value in Health - July 4, 2018 Category: International Medicine & Public Health Authors: Fan Yang, Nancy Devlin, Nan Luo Source Type: research

Psychometric Evaluation of the Patient ’s Knee Implant Performance Questionnaire
To evaluate the psychometric properties of Patient ’s Knee Implant Performance Questionnaire (PKIP), a new patient-reported measure of knee implant functional performance assessing patient experiences before and after primary total knee arthroplasty (TKA). (Source: Value in Health)
Source: Value in Health - July 2, 2018 Category: International Medicine & Public Health Authors: Theresa Coles, Valerie Williams, Kim Dwyer, Margaret Mordin Source Type: research

Prediction of Drug-Related Risks Using Clinical Context Information in Longitudinal Claims Data
To develop and internally validate prediction models for medication-related risks arising from overuse, misuse, and underuse that utilize clinical context information and are suitable for routine risk assessment in claims data (i.e., medication-based models predicting the risk for hospital admission apparent in routine claims data or MEDI-RADAR). (Source: Value in Health)
Source: Value in Health - July 2, 2018 Category: International Medicine & Public Health Authors: Andreas D. Meid, Andreas Groll, Dirk Heider, Sarah M ächler, Jürgen-Bernhard Adler, Christian Günster, Hans-Helmut König, Walter E. Haefeli Source Type: research

Editorial Board
(Source: Value in Health)
Source: Value in Health - July 1, 2018 Category: International Medicine & Public Health Source Type: research

Table of Contents
(Source: Value in Health)
Source: Value in Health - July 1, 2018 Category: International Medicine & Public Health Source Type: research

Copyright/Subscription
(Source: Value in Health)
Source: Value in Health - July 1, 2018 Category: International Medicine & Public Health Source Type: research

Instructions for Authors
(Source: Value in Health)
Source: Value in Health - July 1, 2018 Category: International Medicine & Public Health Source Type: research